Acute Aortic Syndrome Clinical Trial
Official title:
Effects of Ulinastatin on Inflammatory Response for Acute Aortic Syndrome Patients
Acute Aortic Syndrome (AAS) is a common feature of acute aortic wall events, including aortic dissection, intramural hematoma, aortic ulceration and aortic trauma, and occurs in up to 35 cases per 100,000 cases per year between the ages of 65 and 75 years. Ulinastatin has antiinflammatory activity and suppresses the infiltration of neutrophils and the release of elastase and chemical mediators from neutrophils. Recent studies have shown that ulinastatin may be cytoprotective against ischemia-reperfusion injury in the liver, kidney, heart, and lung. The authors aim to examine the association between decreased release of inflammatory response to urinary trypsin inhibitor treatment and decreased myocardial and lung injury after acute aortic syndrome surgery.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03647566 -
18F Sodium Fluoride PET/CT in Acute Aortic Syndrome
|
||
Recruiting |
NCT05965453 -
Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome
|
||
Recruiting |
NCT05339529 -
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Thymosin α1) V
|
N/A | |
Recruiting |
NCT06277895 -
VOCs in Patients With Acute Cardiogenic Chest Pain
|
N/A | |
Completed |
NCT02273245 -
Is a Pre-contrast Scan Necesary to Diagnose Acute Aortic Syndrome?
|
N/A | |
Recruiting |
NCT04699279 -
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Rosuvastatin) I
|
N/A | |
Enrolling by invitation |
NCT04398992 -
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy
|
||
Completed |
NCT04751058 -
Genetic Profile in Patients With Aortic Syndrome
|
||
Completed |
NCT04430400 -
Integrated Diagnostic Algorithm for Acute Aortic Syndromes
|
||
Completed |
NCT01259843 -
French National Observatory of Aortic Syndromes
|